TRANSFAC FACTOR TABLE, Release 2017.2 - public - 2017-06-30, (C) QIAGEN

AC T11270 XX ID T11270 XX DT 19.11.2007 (created); djp. DT 09.05.2014 (updated); asv. CO Copyright (C), QIAGEN. XX FA Pax-3 XX SY hPax-3; hPax3; HuP2; PAX3. XX OS human, Homo sapiens OC eukaryota; animalia; metazoa; chordata; vertebrata; tetrapoda; mammalia; eutheria; primates XX GE G003971 PAX3; HGNC: PAX3. XX CL C0018; paired-homeo; XX CP 501 melanoma cells [2]. XX IN T08334 Sox-10; mouse, Mus musculus. XX MX M00360 V$PAX3_01. MX M08788 V$PAX3_03. MX M00327 V$PAX3_B. MX M00808 V$PAX_Q6. XX BS R72399. BS R61690. BS R33349. BS R33350. BS R33352. BS R34262. BS R22918. XX DR TRANSPATH: MO000118005. DR UniProtKB: P23760; XX RN [1]; RE0024470. RX PUBMED: 12668617. RA Lang D., Epstein J. A. RT Sox10 and Pax3 physically interact to mediate activation of a conserved c-RET enhancer. RL Hum. Mol. Genet. 12:937-945 (2003). RN [2]; RE0024480. RX PUBMED: 10480898. RA Galibert M. D., Yavuzer U., Dexter T. J., Goding C. R. RT Pax3 and regulation of the melanocyte-specific tyrosinase-related protein-1 promoter. RL J. Biol. Chem. 274:26894-26900 (1999). RN [3]; RE0066087. RX PUBMED: 19074888. RA Dissanayake S. K., Olkhanud P. B., O'Connell M. P., Carter A., French A. D., Camilli T. C., Emeche C. D., Hewitt K. J., Rosenthal D. T., Leotlela P. D., Wade M. S., Yang S. W., Brant L., Nickoloff B. J., Messina J. L., Biragyn A., Hoek K. S., Taub D. D., Longo D. L., Sondak V. K., Hewitt S. M., Weeraratna A. T. RT Wnt5A regulates expression of tumor-associated antigens in melanoma via changes in signal transducers and activators of transcription 3 phosphorylation. RL Cancer Res. 68:10205-10214 (2008). RN [4]; RE0066671. RX PUBMED: 19026785. RA Yang G., Li Y., Nishimura E. K., Xin H., Zhou A., Guo Y., Dong L., Denning M. F., Nickoloff B. J., Cui R. RT Inhibition of PAX3 by TGF-beta modulates melanocyte viability. RL Mol. Cell 32:554-563 (2008). XX //